肺腺癌与肺鳞癌N1淋巴结转移对预后影响的差异及相关机制初探OA
Differences in prognostic impact of N1 lymph node metastasis between lung adenocarcinoma and lung squamous cell carcinoma and preliminary exploration of the underlying mechanisms
目的 探讨肺腺癌(LUAD)与肺鳞癌(LUSC)患者N1淋巴结转移对预后的影响差异及潜在机制.方法 回顾性分析2007年1月至2025年5月浙江大学医学院附属第二医院舟山分院行肺癌根治术的3 441例患者(浸润性LUAD 2 977例,LUSC 464例),采用Kaplan-Meier生存曲线分析N1转移对总生存时间(OS)的影响,以癌症基因组图谱(TCGA)数据库验证结果;通过DE-Seq2筛选LUAD与LUSC的N1转移相关差异表达基因(DEGs),行基因本体论(GO)分析和京都基因和基因组百科全书(KEGG)富集分析,并利用Estimate及Cibersort软件包分析肿瘤免疫微环境.结果 LUAD伴N1转移者OS较无转移者显著缩短(P<0.001),而LUSC患者中两者OS差异无统计学意义(P=0.387).从TCGA数据库筛选出LUAD与LUSC的N1差异表达基因1 992个,富集分析显示,LUAD的N1上调基因与细胞迁移、运动及细胞外基质-受体相关信号通路相关,LUSC的N1上调基因则富集于线粒体及能量代谢相关通路.免疫微环境分析表明,LUAD的N1中富集静息CD4+记忆T细胞、M2巨噬细胞、静息树突状细胞等免疫抑制细胞,LUSC的N1则以活化CD4+记忆T细胞、M0/M1巨噬细胞等免疫活化细胞为主.结论 LUAD伴N1转移者OS较无转移者显著缩短,LUSC伴N1转移对患者的OS无明显影响.LUAD的N1上调基因关联细胞迁移及细胞外基质相关通路,其肿瘤微环境以免疫抑制细胞为主;LUSC的N1上调基因富集于能量代谢相关通路,免疫抑制细胞较少.临床应对LUAD伴N1转移者采取更积极的综合治疗,以控制微转移风险,从而改善预后.
Objective To investigate the differences in prognostic impact of N1 lymph node metastasis between patients with lung adenocarcinoma(LUAD)and lung squamous cell carcinoma(LUSC),as well as the potential mechanisms.Methods A retrospective analysis was performed on 3 441 patients who underwent radical resection for lung cancer between January 2007 and May 2025,including 2 977 cases of invasive LUAD and 464 cases of LUSC.Kaplan-Meier survival curves were used to analyze the effect of N1 metastasis on overall survival(OS),and the results were validated using The Cancer Genome Atlas(TCGA)database.Differential expression genes(DEGs)associated with N1 metastasis in LUAD and LUSC were screened by DESeq2,followed by Gene Ontology(GO)analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analysis.The tumor immune microenvironment was analyzed using the Estimate and Cibersort packages.Results OS was significantly shorter in LUAD patients with N1 metastasis than those without N1 metastasis(P<0.001),whereas no significant difference was observed in OS between LUSC patients with and without N1 metastasis(P=0.387).A total of 1 992 N1-related DEGs were identified between LUAD and LUSC from the TCGA database.Enrichment analysis showed that upregulated genes in N1-positive LUAD were associated with signaling pathways related to cell migration,motility and extracellular matrix-receptor interactions,whereas upregulated genes in N1-positive LUSC were mainly enriched in mitochondrial function and energy metabolism pathways.Immune microenvironment analysis revealed that N1-positive LUAD was enriched in immunosuppressive cells such as resting CD4+memory T cells,M2 macrophages and resting dendritic cells,while N1-positive LUSC was predominantly infiltrated with immunocompetent cells including activated CD4+memory T cells and M0/M1 macrophages.Conclusion The OS of patients with LUAD accompanied by N1 metastasis was significantly shorter than that of patients without metastasis,while LUSC accompanied by N1 metastasis had no significant effect on the OS of patients.Upregulated genes in N1-positive LUAD are involved in cell migration and extracellular matrix-related pathways,with immunosuppressive cells dominated in tumor microenvironment.In contrast,upregulated genes in N1-positive LUSC are enriched in energy metabolism pathways with fewer immunosuppressive cells.Clinically,more aggressive comprehensive therapy should be adopted for LUAD patients with N1 metastasis to control the risk of micrometastasis and improve prognosis.
陈宸;竺王玉;乐涵波
316021 浙江大学医学院附属第二医院舟山分院胸心外科316021 浙江大学医学院附属第二医院舟山分院细胞分子生物实验室316021 浙江大学医学院附属第二医院舟山分院胸心外科
肺腺癌肺鳞癌肿瘤转移预后基因差异表达肿瘤免疫微环境
Lung adenocarcinomaLung squamous cell carcinomaNeoplasm metastasisPrognosisDifferential expression geneTumor immune microenvironment
《浙江医学》 2026 (5)
458-463,470,后插2-后插3,9
国家中医药综合改革示范区科技共建项目(GZY-KJS-ZJ-2025-091)舟山市科技计划重点项目(2023C31001)
评论